127 related articles for article (PubMed ID: 11799994)
21. Nonoxynol-9 and the reduction of HIV transmission in women.
Gollub EL; Stein Z
AIDS; 1992 Jun; 6(6):599-601. PubMed ID: 1326995
[No Abstract] [Full Text] [Related]
22. Need for a true placebo for vaginal microbicide efficacy trials.
Kilmarx PH; Paxton L
Lancet; 2003 Mar; 361(9359):785-6; author reply 786. PubMed ID: 12620765
[No Abstract] [Full Text] [Related]
23. In vivo effects of nonoxynol-9 on endometrial immune cell populations.
Rahangdale L; Greenblatt RM; Perry J; Darragh TM; Kobayashi A; Smith-McCune KK
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):137-9. PubMed ID: 19704265
[No Abstract] [Full Text] [Related]
24. Nonoxynol-9 ineffective in preventing HIV infection.
Indian J Med Sci; 2002 Sep; 56(9):467-8. PubMed ID: 12710347
[No Abstract] [Full Text] [Related]
25. Acceptability and feasibility of a clinical trial to assess the efficacy of a microbicide-containing vaginal gel to prevent HIV infection among female sex workers in Abidjan, Côte d'Ivoire.
Ettiègne-Traoré V; Ghys PD; Van Damme L; N'Krumah M; Maïga A; Tiémelé A; Mah-bi G; Coulibaly IM; Laga M; Greenberg AE
AIDS; 1997 Nov; 11(13):1660-2. PubMed ID: 9365779
[No Abstract] [Full Text] [Related]
26. Microbicides for preventing transmission of genital herpes.
Zeitlin L; Whaley KJ
Herpes; 2002 Apr; 9(1):4-9. PubMed ID: 11916493
[TBL] [Abstract][Full Text] [Related]
27. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
Raymond EG; Chen PL; Luoto J;
Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
[TBL] [Abstract][Full Text] [Related]
28. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
[TBL] [Abstract][Full Text] [Related]
29. Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men.
Wilkinson D; Ramjee G; Tholandi M; Rutherford G
Cochrane Database Syst Rev; 2002; 2002(4):CD003936. PubMed ID: 12519622
[TBL] [Abstract][Full Text] [Related]
30. 'Ideal' microbicide may be best form of protection.
AIDS Alert; 1999 Feb; 14(2):suppl 3-4. PubMed ID: 11366179
[TBL] [Abstract][Full Text] [Related]
31. Microbicides. Raising new barriers against HIV infection.
Trager RS
Science; 2003 Jan; 299(5603):39. PubMed ID: 12511630
[No Abstract] [Full Text] [Related]
32. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
Van Damme L; Ramjee G; Alary M; Vuylsteke B; Chandeying V; Rees H; Sirivongrangson P; Mukenge-Tshibaka L; Ettiègne-Traoré V; Uaheowitchai C; Karim SS; Mâsse B; Perriëns J; Laga M;
Lancet; 2002 Sep; 360(9338):971-7. PubMed ID: 12383665
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of nonoxynol-9 from an in vitro point of view.
Bourinbaiar AS; Fruhstorfer EC
AIDS; 1996 May; 10(5):558-9. PubMed ID: 8724057
[No Abstract] [Full Text] [Related]
34. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
[TBL] [Abstract][Full Text] [Related]
35. What's up with nonoxynol-9?
Forbes A; Heise L
Reprod Health Matters; 2000 Nov; 8(16):156-9. PubMed ID: 11424245
[TBL] [Abstract][Full Text] [Related]
36. Vaginal viricides-another way to tackle HIV transmission.
Berger A
BMJ; 1998 Oct; 317(7165):1053. PubMed ID: 9774291
[No Abstract] [Full Text] [Related]
37. Clinical microbicide research: an overview.
Van Damme L
Trop Med Int Health; 2004 Dec; 9(12):1290-6. PubMed ID: 15598260
[TBL] [Abstract][Full Text] [Related]
38. Disruption of the upper female reproductive tract epithelium by nonoxynol-9.
Dayal MB; Wheeler J; Williams CJ; Barnhart KT
Contraception; 2003 Oct; 68(4):273-9. PubMed ID: 14572891
[TBL] [Abstract][Full Text] [Related]
39. Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.
Lozenski K; Ownbey R; Wigdahl B; Kish-Catalone T; Krebs FC
BMC Pharmacol Toxicol; 2012 Oct; 13():9. PubMed ID: 23025553
[TBL] [Abstract][Full Text] [Related]
40. Nonoxynol-9 vaginal pessary: a preliminary Indian experience.
Yadav SC; Gaur LN; Gupta N; Roy M; Saxena NC
Natl Med J India; 2006; 19(3):133-6. PubMed ID: 16836262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
